Product Information
SILDENAFIL 50 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1067 per EA under NDC 72888001600. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application on Jun 11, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888001600
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SILDENAFIL CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA204882FDA Approved
6/11/2018
TE Code
AB
On Market Since
6/17/2021
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 50 MG TABLET has been published 243 times since Feb 9, 2022, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.2533 (Oct 12, 2022) |
| All-time low | $0.0852 (Nov 20, 2024) |
| 52-week high | $0.1135 |
| 52-week low | $0.1027 |
| Median price | $0.1286 |
| Average price | $0.1520 |
| Largest weekly change | +30.6% (Aug 21, 2024) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sildenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 50 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1067 per EA (NDC 72888001600), effective Sep 30, 2026.
How has the price of SILDENAFIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 50 MG TABLET has declined 43.6%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 50 MG TABLET?
Since Feb 9, 2022, the NADAC for SILDENAFIL 50 MG TABLET has ranged from a low of $0.0852 (Nov 20, 2024) to a high of $0.2533 (Oct 12, 2022), with a median of $0.1286 per EA.
Are there cheaper alternatives to SILDENAFIL 50 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SILDENAFIL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SILDENAFIL 50 MG TABLET?
SILDENAFIL 50 MG TABLET (NDC 72888001600) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.